Human Anti-FPR1 Recombinant Antibody (clone Fpro0165) (CAT#: PABL-097)

Recombinant Human Antibody (Fpro0165) is capable of binding to FPR1, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-FPR1 mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-FPR1 mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA

Figure 1 FACS staining was carried out using Fpro0165 IgG1 and control IgG1 with parental, human FPR2-overexpressing and human CXCR3-overexpressing HEK cells to determine the binding specificity of Fpor0165 to FPR1.

Figure 1 FACS staining was carried out using Fpro0165 IgG1 and control IgG1 with parental, human FPR2-overexpressing and human CXCR3-overexpressing HEK cells to determine the binding specificity of Fpor0165 to FPR1.

Douthwaite, J. A., Sridharan, S., Huntington, C., Hammersley, J., Marwood, R., Hakulinen, J. K.,... & Seaman, J. C. (2015, January). Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1. In MAbs (Vol. 7, No. 1, pp. 152-166). Taylor & Francis.

Figure 2 Lack of inhibition of WKYMVM-induced calcium release in FPR2-overexpressing cells by Fpro0165 (B, right panel). Different agonist activity of the FPR1-specific formyl peptides fMLFF (EC50 not quoted, incomplete curve) and fMIFL (EC50, 0.12 nM on FPR1 cells) and FPR2-specific peptide WKYMVM (EC50, 0.49 nM on FPR2 cells) are shown in the left and center panels confirming the overexpression of FPR1 and FPR2 respectively.

Figure 2 Lack of inhibition of WKYMVM-induced calcium release in FPR2-overexpressing cells by Fpro0165 (B, right panel). Different agonist activity of the FPR1-specific formyl peptides fMLFF (EC50 not quoted, incomplete curve) and fMIFL (EC50, 0.12 nM on FPR1 cells) and FPR2-specific peptide WKYMVM (EC50, 0.49 nM on FPR2 cells) are shown in the left and center panels confirming the overexpression of FPR1 and FPR2 respectively.

Douthwaite, J. A., Sridharan, S., Huntington, C., Hammersley, J., Marwood, R., Hakulinen, J. K.,... & Seaman, J. C. (2015, January). Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1. In MAbs (Vol. 7, No. 1, pp. 152-166). Taylor & Francis.

Figure 3 Determination of the apparent affinity of Fpro0165 for human FPR1 and cynomolgus FPR1 using Schild analysis of activity in a CD11b upregulation assay using in primary human and cynomolgus neutrophils.

Figure 3 Determination of the apparent affinity of Fpro0165 for human FPR1 and cynomolgus FPR1 using Schild analysis of activity in a CD11b upregulation assay using in primary human and cynomolgus neutrophils.

Concentrationresponse curves of fMLFF induced CD11b expression in primary human (A) and cynomolgus (B) neutrophils in the absence (0) or presence of different concentrations Fpro0165 IgG (indicated in the key as logM). Schild plot analysis of the data derived from human (C) and cynomolgus (D) assays to generate the apparent Kd of the antibody. Dose ratios were generated using 50% response levels of fMLFF in the presence of antibody and log (dose ratio-1) was plotted against log [antibody] (M). The x-intercept of the fitted regression line is an estimate of pA2, the apparent equilibrium dissociation constant for the antibody.

Douthwaite, J. A., Sridharan, S., Huntington, C., Hammersley, J., Marwood, R., Hakulinen, J. K.,... & Seaman, J. C. (2015, January). Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1. In MAbs (Vol. 7, No. 1, pp. 152-166). Taylor & Francis.


Specifications

  • Immunogen
  • Human formyl peptide receptor 1
  • Host Species
  • Human
  • Type
  • Human IgG
  • Specificity
  • Human FPR1
  • Species Reactivity
  • Human
  • Clone
  • Fpro0165
  • Applications
  • FC, FuncS

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The antibody was validated for Flow Cytometry and Inhibition. For details, refer to published data.

Target

  • Alternative Names
  • FPR1; formyl peptide receptor 1; FPR; FMLP; fMet-Leu-Phe receptor; fMLP receptor; N-formylpeptide chemoattractant receptor

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone Fpro0165"

See other products for "FPR1"

Recombinant Antibody

scFv Fragment Antibody

CAT Product Name Application Type
PSBL-097 Human Anti-FPR1 Recombinant Antibody (clone Fpro0165); scFv Fragment FC, FuncS Human scFv

Fab Fragment Antibody

CAT Product Name Application Type
PFBL-097 Human Anti-FPR1 Recombinant Antibody (clone Fpro0165); Fab Fragment FC, FuncS Human Fab

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABL-097. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare